title: Serum anti-PLA2R antibodies may be present before clinical manifestations of membranous nephropathy.
authors.affiliation: Department of Nephrology, Valenciennes Hospital, France.
authors.forename: Mary-Jane
authors.initials: MJ
authors.lastname: Guerry
authors.affiliation: Department of Nephrology, Valenciennes Hospital, France.
authors.forename: Philippe
authors.initials: P
authors.lastname: Vanhille
authors.affiliation: Sorbonne Universités, Université Pierre et Marie Curie Université Paris 06, Unité Mixte de Recherche_S 1155, Paris, France; Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche_S 1155, Paris, France; Assistance Publique-Hôpitaux de Paris, Hôpital Tenon, Department of Nephrology and Dialysis, Paris, France.
authors.forename: Pierre
authors.initials: P
authors.lastname: Ronco
authors.affiliation: Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche_S 1155, Paris, France; Assistance Publique-Hôpitaux de Paris, Hôpital Tenon, Department of Nephrology and Dialysis, Paris, France. Electronic address: hanna.debiec@upmc.fr.
authors.forename: Hanna
authors.initials: H
authors.lastname: Debiec
mesh_terms: D000368:Aged; D001323:Autoantibodies / Q000097:blood*; D001706:Biopsy; D003404:Creatinine / Q000097:blood; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000379:methods; D004797:Enzyme-Linked Immunosorbent Assay; D005455:Fluorescent Antibody Technique; D015433:Glomerulonephritis, Membranous / Q000097:blood* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D005923:Glomerulosclerosis, Focal Segmental / Q000097:blood* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007668:Kidney / Q000473:pathology; D008297:Male; D054507:Receptors, Phospholipase A2 / Q000276:immunology*; D000069283:Rituximab / Q000627:therapeutic use
chemical_list: D001323:Autoantibodies; D005938:Glucocorticoids; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D054507:Receptors, Phospholipase A2; D000069283:Rituximab; D003520:Cyclophosphamide; D003404:Creatinine